Ignite Creation Date:
2024-05-06 @ 8:42 AM
Last Modification Date:
2024-10-26 @ 12:04 PM
Study NCT ID:
NCT02807558
Status:
COMPLETED
Last Update Posted:
2024-01-19
First Post:
2016-06-13
Brief Title:
A Biomarker-Directed Phase 2 Trial of Tamibarotene SY-1425 in Participants With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Sponsor:
Syros Pharmaceuticals
Organization:
Syros Pharmaceuticals
Organization Data
Organization:
Syros Pharmaceuticals
Class:
INDUSTRY
Study ID:
SY-1425-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Syros Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None